Search

Your search keyword '"Lutgens, Ludy"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Lutgens, Ludy" Remove constraint Author: "Lutgens, Ludy"
144 results on '"Lutgens, Ludy"'

Search Results

101. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers

102. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition

103. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials

104. Prostate IGRT using quantitative 3D ultrasound imaging: Intramodality US vs. MV imaging of implanted markers (Conference Abstract)

105. Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop.

106. Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial

108. Synopsis of Partial-Body Radiation Diagnostic Biomarkers and Medical Management of Radiation Injury Workshop

110. Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial

111. Radiotherapy and Hyperthermia for Treatment of Primary Locally Advanced Cervix Cancer: Results in 378 Patients

118. Survival After Relapse in Patients With Endometrial Cancer: Results From a Randomized Trial

120. AIRMEC - an Artificial Intelligence Model to Predict the Molecular Endometrial Cancer Classification from H&E Images

122. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.

123. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.

124. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia.

125. Treatment verification in high dose rate brachytherapy using a realistic 3D printed head phantom and an imaging panel

127. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non–small-cell lung cancer: A modeling study

129. Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.

130. Prediction of recurrence risk in endometrial cancer with multimodal deep learning.

131. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.

132. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.

133. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.

134. Treatment verification in high dose rate brachytherapy using a realistic 3D printed head phantom and an imaging panel.

135. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.

136. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer.

137. Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study.

138. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.

139. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.

140. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study.

141. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.

142. [Rectal bleeding after radiotherapy for prostate cancer].

143. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers.

144. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer.

Catalog

Books, media, physical & digital resources